A detailed history of Harrison & CO Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harrison & CO Wealth Management, LLC holds 14,707 shares of BMY stock, worth $778,000. This represents 1.03% of its overall portfolio holdings.

Number of Shares
14,707
Previous 14,813 0.72%
Holding current value
$778,000
Previous $1.05 Million 0.47%
% of portfolio
1.03%
Previous 1.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

SELL
$68.48 - $81.09 $7,258 - $8,595
-106 Reduced 0.72%
14,707 $0
Q3 2022

Oct 18, 2022

SELL
$0.13 - $76.84 $130 - $76,993
-1,002 Reduced 6.34%
14,813 $1.05 Million
Q2 2022

Jul 11, 2022

BUY
$72.62 - $79.98 $4,139 - $4,558
57 Added 0.36%
15,815 $1.22 Million
Q1 2022

Apr 18, 2022

BUY
$61.48 - $73.72 $46,724 - $56,027
760 Added 5.07%
15,758 $1.15 Million
Q4 2021

Jan 31, 2022

BUY
$53.63 - $62.52 $804,342 - $937,674
14,998 New
14,998 $935,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harrison & CO Wealth Management, LLC Portfolio

Follow Harrison & CO Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrison & CO Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harrison & CO Wealth Management, LLC with notifications on news.